S3 show the results for the outcome MACE: both GLP-1RA and SGLT-2 inhibitors were associated with a lower risk for MACE (13% and 11%, respectively) as compared with placebo, and a lower risk for MACE as compared with DPP-4 inhibitors (12% and 11%, respectively)
doi: 10.1152/ajpendo.00361.2023
Underlying health conditionssuch as insulin resistance, type 2 diabetes, PCOS, menopause-related hormonal changes, or the use of certain medicationscan also affect how quickly and how much weight changes over time
Real founders, real credentials
Many people rely on both methods, using injections to see quick results and oral supplements to maintain balanced levels over time
BPC-157 (cytoprotection + VEGF angiogenesis) + TB-500 (G-actin sequestration + cell migration) + GHK-Cu (collagen + matrix induction) co-lyophilized for connective-tissue research